A novel Schizochytrium strain having high intracellular oil content and a method for producing an oil containing omega-3 using the same

The novel Schizochytrium sp. strain CD01-1821 addresses sustainability and quality issues in DHA and EPA production by enabling efficient, scalable microbial cultivation for feed and food compositions with high DHA and EPA content.

JP2024542170AActive Publication Date: 2024-11-13CJ CHEILJEDANG CORP
View PDF 8 Cites 0 Cited by

Patent Information

Application Number
JP2024527175
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-11-08
Filing Date
2022-08-10
Publication Date
2024-11-13
Estimated Expiration
2042-08-10

AI Technical Summary

Technical Problem

Current methods for producing polyunsaturated fatty acids like docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) face challenges such as variability in quality and sustainability due to fishing limitations, contamination issues, and oxidation problems in fish oil, while microbial production methods offer stability but require improved strains for efficient industrial-scale cultivation.

Method used

Development of a novel Schizochytrium sp. strain CD01-1821 with high intracellular DHA and EPA content, optimized for heterotrophic cultivation using complex sugars, enabling efficient biomass and bio-oil production suitable for feed and food compositions.

Benefits of technology

The novel strain achieves high DHA and EPA content, facilitating stable, scalable production of biomass and bio-oil with improved yield and reduced production time, suitable for feed and food applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024542170000001_ABST
    Figure 2024542170000001_ABST
Patent Text Reader

Abstract

The present application relates to a novel Schizochytrium sp. strain having a high intracellular oil content and a method for producing an oil containing omega-3 using the same, and the novel Schizochytrium sp. microalgae according to the present invention has a high fat content in the biomass, in particular a high content of unsaturated fatty acids such as docosahexaenoic acid and eicosapentaenoic acid, so that it is very easy to extract the biomass itself or the biomass produced by culture and fermentation, and the fat components containing unsaturated fatty acids from the biomass. Therefore, the microalgae, the dried biomass and the bio-oil produced therefrom can be usefully used in feed compositions or food compositions.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] [CROSS REFERENCE TO RELATED APPLICATIONS] This application claims the benefit of priority based on Korean Patent Application No. 10-2021-0152561 dated November 8, 2021, and all contents disclosed in the documents of that Korean patent application are incorporated herein by reference.

[0002] The present application relates to a novel Schizochytrium sp. strain having a high intracellular oil content and a method for producing an oil containing omega-3 using the same. [Background technology]

[0003] Thraustochytrids live and distribute in various environments in nature. They attach to organisms and live in symbiosis, or float in marine, freshwater, or brackish environments, and live distributed in various sedimentary layers. These Thraustochytrids belong to the lowest level of the marine ecological food chain and are sometimes classified as phytoplankton and organoheterotrophic protists, or microalgae. In the natural environment, Thraustochytrids play a role in circulating and purifying natural circulating elements such as sulfur, nitrogen, phosphorus, and potassium. They also contain high concentrations of polyunsaturated fatty acids (PUFAs), including docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), which are classified as omega-3, and function as a source of nutrients in the marine ecosystem.

[0004] Most higher organisms, including humans, cannot synthesize polyunsaturated fatty acids, including docosahexaenoic acid and eicosapentaenoic acid, on their own, so they must ingest them as essential nutrients. Among polyunsaturated fatty acids, docosahexaenoic acid and eicosapentaenoic acid are essential fatty acids for the brain, eyeball tissue, and nervous system, and are known to play important roles in the development of the nervous system, particularly in infants' vision and motor skills, and in preventing cardiovascular disease. They are also the most abundant components of structural lipids in the brain.

[0005] Until now, the main source of polyunsaturated fatty acids has been fish oil extracted from blue-backed fish such as mackerel, pacific saury, tuna, horse mackerel, sardines, and herring, which is also very useful as fish feed, such as the initial feed for marine fish. Although the extraction and intake of polyunsaturated fatty acids from fish oil has been developed industrially, there are also disadvantages. The quality of fish oil varies depending on the fish species, season, and fishing location, and it is difficult to continuously supply it because it is generated through fishing. In addition, there are restrictions on the manufacturing process and production volume due to contamination issues caused by heavy metals and organic chemicals contained in fish oil, the fishy smell unique to fish oil, and the problem of oxidation of double bonds during the processing process.

[0006] In order to solve these problems, research has been conducted recently on a method for producing polyunsaturated fatty acids, including docosahexaenoic acid and eicosapentaenoic acid, by microbial culture. In particular, microalgae can provide various advantages over fish oil in addition to the ability to naturally synthesize fatty acids de novo. They can be stably supplied through industrial-scale culture, allowing the production of biomass with a relatively constant biochemical composition. Unlike fish oil, lipids produced by microalgae do not have any unpleasant odor. They also have a simple fatty acid composition compared to fish oil, which makes the step of separating the major fatty acids easier.

[0007] Based on these advantages, research and industrialization into the production of polyunsaturated fatty acids, including omega-3 unsaturated fatty acids such as docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), arachidonic acid (ARA), docosapentaenoic acid (DPA), and α-linolenic acid, using microalgae, has been progressing very rapidly in recent years, and polyunsaturated fatty acids are mainly produced by microorganisms of the genera Thraustochytrium and Schizochytrium, which are types of marine microalgae. As examples, a method for producing omega-3 polyunsaturated fatty acids using Schizochytrium sp. ATCC20888 and Schizochytrium sp. PTA10208, which are Schizochytrium microorganisms, has been disclosed (U.S. Patent Nos. 5,130,242), and further a method for producing docosahexaenoic acid and eicosapentaenoic acid using Thraustochytrid microorganisms of the genus Thraustochytrium, Thraustochytrium sp. ATCC10212, has been disclosed. [Prior art documents] [Patent documents]

[0008] [Patent Document 1] U.S. Patent No. 5,130,242 Summary of the Invention [Problem to be solved by the invention]

[0009] An example of the present application provides a novel Schizochytrium sp. microalgae. In one specific example, the novel Schizochytrium sp. microalgae may be Schizochytrium sp. CD01-1821 microalgae (Accession Number: KCTC14660BP).

[0010] Another embodiment of the present application provides a biomass or bio-oil derived from the Schizochytrium microalgae.

[0011] Another example of the present application provides a feed composition comprising biomass, bio-oil, or a combination thereof derived from the Schizochytrium microalgae.

[0012] Another example of the present application provides a food composition comprising biomass, bio-oil, or a combination thereof derived from the Schizochytrium microalgae.

[0013] Another embodiment of the present application provides a method for producing biomass or bio-oil derived from the Schizochytrium microalgae.

[0014] Another example of the present application provides a use of the Schizochytrium microalgae for producing biomass or bio-oil.

[0015] Yet another embodiment of the present application provides a use of the Schizochytrium microalgae for producing a feed composition or a food composition. [Means for solving the problem]

[0016] Each description and embodiment disclosed in this application may be applied to each other description and embodiment. In other words, all combinations of the various elements disclosed in this application belong to the scope of this application. In addition, the specific descriptions described below are not intended to limit the scope of this application. In addition, a person skilled in the art will recognize or be able to ascertain, through no more than routine experimentation, numerous equivalents to the specific aspects of this application described in this application. In addition, such equivalents are intended to be included in this application.

[0017] One example of the present application provides a novel Schizochytrium sp. microalgae.

[0018] The term "Thraustochytrid" as used herein means microalgae of the order Thraustochytriales. The term "Schizochytrium sp." as used herein means one of the genus names belonging to the family Thraustochytriaceae of the order Thraustochytriales, and may be used interchangeably with the term "genus Schizochytrium." The term "microalgae" means an organism that can be seen only through a microscope, not with the naked eye, among plants that perform photosynthesis using chlorophyll, and that lives floating freely in water. There are various types of microalgae, including strains that cannot photosynthesize and grow only heterotrophically.

[0019] In this application, as an example, environmental samples were collected from coastal areas to obtain pure isolated colonies of Thraustochytrids. Then, as a result of analysis of crude fat and fatty acid, two strains, CD01-1821 and CD01-1822, with excellent intracellular DHA content were obtained. As a result of culture evaluation, it was confirmed that CD01-1821 strain has high total biomass production and total oil content under the same fermentation conditions, and therefore is easier to scale up.

[0020] Therefore, in the present specification, the novel Schizochytrium sp. microalgae may be Schizochytrium sp. CD01-1821 microalgae (accession number: KCTC14660BP).

[0021] Furthermore, the (wild-type) Schizochytrium strain may have an 18s rRNA base sequence of SEQ ID NO: 1, but is not limited thereto. For example, the Schizochytrium microalga may have an 18S rRNA composed of a base sequence that shows 80% or more, 85% or more, 90% or more, 95% or more, 98% or more, or 99% or more sequence identity to the base sequence of SEQ ID NO: 1, but is not limited thereto.

[0022] As used herein, the term "docosahexaenoic acid (DHA)" refers to 22 H 32 It is one of the polyunsaturated fatty acids with the chemical formula O2, and along with alpha-linolenic acid (ALA) and eicosapentaenoic acid (EPA), it is classified as an omega-3 fatty acid. Its common name is cervonic acid, and it can also be abbreviated as 22:6n-3.

[0023] As used herein, the term "eicosapentaenoic acid (EPA)" refers to C 20 H 30It is a polyunsaturated fatty acid with the chemical formula O2, and along with ALA and DHA, it belongs to the omega-3 fatty acids and can also be abbreviated as 20:5n-3.

[0024] The Schizochytrium microalgae may produce and / or contain 35 to 60% by weight of DHA based on the total weight of fatty acids. For example, the Schizochytrium microalgae may produce and / or contain 40 to 65% by weight, 45 to 65% by weight, 50 to 65% by weight, 40 to 60% by weight, 45 to 60% by weight, 50 to 60% by weight, (35 to 58% by weight, 40 to 58% by weight, 45 to 58% by weight, or 48 to 52% by weight) or 55 to 60% by weight of DHA based on the total weight of fatty acids.

[0025] The Schizochytrium microalgae may produce and / or contain 0.1 to 2 wt% EPA based on the total weight of fatty acids. For example, the Schizochytrium microalgae may produce and / or contain 0.2 to 2 wt%, 0.2 to 1.5 wt%, 0.2 to 1 wt%, 0.3 to 2 wt%, 0.3 to 1.5 wt%, 0.3 to 1 wt%, 0.5 to 2 wt%, 0.5 to 1.5 wt%, 0.5 to 1 wt%, 0.5 to 0.9 wt%, or 0.6 to 0.8 wt% EPA based on the total weight of fatty acids.

[0026] Another aspect of the present application provides a biomass or bio-oil derived from Schizochytrium microalgae, including the Schizochytrium CD01-1821 microalgae, a culture of the microalgae, a dried product of the culture, or a crushed product of the dried product.

[0027] The Schizochytrium microalgae are as described above.

[0028] The term "biomass" as used herein means an organism such as a plant, animal, or microorganism that can be used as chemical energy, i.e., an energy source of bioenergy, and may also mean the weight or amount of energy of a specific organism present within a unit of time and space ecologically. The biomass may include, but is not limited to, compounds secreted by cells, and may contain not only extracellular substances but also intracellular and / or intracellular contents. In the present application, the biomass may be Schizochytrium microalgae itself, a culture thereof, a dried product thereof, a crushed product thereof, or a product produced by culturing or fermenting the microalgae, or may be, but is not limited to, a concentrate or dried product of the biomass.

[0029] The "culture" of the Schizochytrium microalgae refers to a product produced by culturing the microalgae, and may be specifically a culture solution containing the microalgae or a culture filtrate obtained by removing the microalgae from the culture solution, but is not limited thereto. The "dried product" of the Schizochytrium microalgae culture refers to the microalgae culture from which water has been removed, and may be, for example, a dried cell form of the microalgae, but is not limited thereto. In addition, the "crushed product" of the dried product refers to a product obtained by crushing the dried product from which water has been removed from the microalgae culture, and may be, for example, a dried cell powder, but is not limited thereto. The Schizochytrium microalgae culture may be produced by inoculating the microalgae into a microalgae culture medium and culturing the microalgae according to a culturing method known in the art, and the dried product of the culture and the crushed product may also be produced by a processing or drying method of the microalgae or culture solution known in the art.

[0030] The biomass from the Schizochytrium genus CD01-1821 microalgae may contain 40 to 85%, 45 to 80%, 50 to 75%, 50 to 70%, or 54 to 66% crude fat by weight based on the total weight of the biomass.

[0031] The biomass derived from the Schizochytrium microalgae may contain 5 to 25% by weight, 5 to 20% by weight, 10 to 20% by weight, or 15 to 20% by weight of crude protein based on the total weight of the biomass.

[0032] The biomass derived from the Schizochytrium microalgae may contain 35% by weight or more, or 35 to 60% by weight of DHA based on the total weight of fatty acids, may contain 0.1% by weight or more, or 0.1 to 2% by weight of EPA based on the total weight of fatty acids, and may contain 30 to 40% by weight or more of palmitic acid based on the total weight of fatty acids.

[0033] The Schizochytrium microalgae has a high oil content, including a high omega-3 content, which is advantageous for the scale-up process by shortening the culture time in complex sugars.

[0034] As used herein, the term "oil content" may be used interchangeably with "crude fat content."

[0035] The biomass may be produced by a method for producing biomass derived from Schizochytrium microalgae according to one embodiment.

[0036] Another aspect of the present application provides a composition comprising Schizochytrium sp. CD01-1821 microalgae, a culture of the microalgae, a dried product of the culture, or a crushed product of the dried product.

[0037] The composition may comprise biomass, bio-oil, or a combination thereof derived from the Schizochytrium microalgae.

[0038] Another aspect of the present application provides a feed composition comprising biomass derived from Schizochytrium sp. CD01-1821 microalgae, or a concentrate or dry matter of said biomass.

[0039] The Schizochytrium microalgae, the biomass, the culture of the microalgae, the dried product of the culture, and the crushed product of the dried product are as described above.

[0040] The biomass concentrate or dry matter may be produced by any method known in the art for processing, concentrating or drying microbial biomass.

[0041] As used herein, the term "bio-oil" refers to oil obtained from biomass by biological, thermochemical and physicochemical extraction processes, and the bio-oil produced in this application may contain polyunsaturated fatty acids, specifically, but is not limited to, DHA and EPA.

[0042] As used herein, the bio-oil may include an extract of a biomass.

[0043] The method for producing the bio-oil extract may include, but is not limited to, a method using enzymes such as protease, cellulase, pectinase, or chitinase to disrupt or dissolve cell membranes or cell wall components, a method using a homogenizer, an ultrasonic crusher, bead processing, or the like to physically disrupt cell membranes or cell wall components, a method of directly adding a solvent and extracting by permeation into cells, and a solvent-free extraction process in which separation is performed through a centrifugation process after various disruption processes.

[0044] The composition may be in the form of, but is not limited to, a solution, a powder, or a suspension, and may be, for example, a food composition, a feed composition, or a feed additive composition.

[0045] The term "feed composition" as used herein refers to a feed that is fed to an animal. The feed composition refers to a substance that provides organic or inorganic nutrients necessary for sustaining the life of an animal or producing meat, milk, etc. The feed composition may additionally contain nutritional components necessary for sustaining the life of an animal or producing meat, milk, etc. The feed composition may be prepared as various forms of feed known in the art, and may specifically include concentrated feed, roughage, and / or special feed.

[0046] The term "feed additive" as used herein includes substances added to feed for various purposes such as supplementing nutrients and preventing weight loss, increasing the digestive availability of fiber in feed, improving milk quality, preventing reproductive disorders and improving conception rates, preventing high temperature stress in summer, etc. The feed additive of the present application corresponds to a supplementary feed under the Feed Management Act, and may additionally include mineral preparations such as sodium bicarbonate, bentonite, magnesium oxide, complex minerals, mineral preparations of trace minerals such as zinc, copper, cobalt, selenium, etc., vitamin preparations such as keratin, vitamin E, vitamin A, D, E, nicotinic acid, vitamin B complex, etc., protected amino acid preparations such as methionine, lysine, etc., protected fatty acid preparations such as fatty acid calcium salts, probiotics (lactic acid bacteria preparations), live bacteria such as yeast cultures and mold fermentation products, yeast preparations, etc.

[0047] The term "food composition" as used herein includes all forms of functional foods, nutritional supplements, health foods, and food additives, and the food compositions of the above types can be prepared in various forms by conventional methods known in the art.

[0048] The compositions of the present application may further comprise grains, such as crushed or crushed wheat, oats, barley, corn and rice; vegetable protein feeds, such as feeds based on soybeans and sunflower; animal protein feeds, such as blood meal, meat meal, bone meal and fish meal; dry ingredients consisting of sugars and dairy products, such as various milk powders and whey powders, and may further comprise other nutritional supplements, digestion and absorption enhancers, growth promoters, etc.

[0049] The compositions of the present application may be administered to animals alone or in combination with other feed additives in an edible carrier. The compositions may also be administered to animals as a top dressing or by mixing them directly into the feed or in an oral formulation separate from the feed. When the compositions are administered separately from the feed, they may be combined with a pharma- ceutically acceptable edible carrier to produce immediate or sustained release formulations, as is well known in the art. Such edible carriers may be solid or liquid, such as corn starch, lactose, sucrose, soybean flakes, peanut oil, olive oil, sesame oil, and propylene glycol. When a solid carrier is used, the composition may be a tablet, capsule, powder, lozenge, or lozenge or top dressing in microdispersible form. When a liquid carrier is used, the composition may be in the form of a soft gelatin capsule, or a syrup, suspension, emulsion, or solution.

[0050] The composition of the present application may contain, for example, a preservative, a stabilizer, a wetting or emulsifying agent, a cryoprotectant, or an excipient, etc. The cryoprotectant may be one or more selected from the group consisting of glycerol, trehalose, maltodextrin, skim milk powder, and starch.

[0051] The preservative, stabilizer, or excipient may be contained in the composition in an effective amount sufficient to reduce deterioration of the Schizochytrium microalgae contained in the composition, and the cryoprotectant may be contained in the composition in an effective amount sufficient to reduce deterioration of the Schizochytrium microalgae contained in the composition when the composition is in a dried state.

[0052] The composition may be applied by immersion, spraying or mixing into the animal feed.

[0053] The composition of the present application can be applied to the feed of many animals, including, but not limited to, mammals, birds, fish, crustaceans, cephalopods, reptiles and amphibians. For example, the mammals can include pigs, cows, sheep, goats, laboratory rodents, or pet animals, and the birds can include poultry, which can include, but are not limited to, chickens, turkeys, ducks, geese, pheasants, or quails. The fish can also include commercially farmed fish and their juveniles, ornamental fish, and the crustaceans can include, but are not limited to, shrimp, barnacles, and the like. The composition can also be applied to the feed of rotifers of zooplankton.

[0054] Another aspect of the present application provides a method for producing biomass derived from Schizochytrium sp. CD01-1821 microalgae, the method including the steps of culturing the microalgae, and recovering biomass from the microalgae, a culture of the microalgae, a dried product of the culture, or crushed products of the dried product.

[0055] The Schizochytrium microalgae, the biomass, the culture of the microalgae, the dried product of the culture, and the crushed product of the dried product are as described above.

[0056] As used herein, the term "cultivation" refers to growing the microalgae under appropriately controlled environmental conditions. The culturing process of the present application may be performed using appropriate media and culture conditions known in the art. Such a culturing process may be easily adjusted by a person skilled in the art depending on the selected microalgae.

[0057] Specifically, the cultivation of the Schizochytrium microalgae of the present application may be carried out under heterotrophic conditions, but is not limited thereto.

[0058] The term "heterotrophy" as used herein refers to a nutritional method that depends on external organic matter for energy or nutrient sources, and corresponds to autotrophy, and may be used interchangeably with the term "dark culture."

[0059] The step of culturing the Schizochytrium microalgae is not particularly limited, and may be performed by known batch culture methods, continuous culture methods, fed-batch culture methods, etc. The medium and other culture conditions used for culturing the microalgae of the present application may be any medium used for culturing normal microalgae without any particular limitations. Specifically, the microalgae of the present application may be cultured in a normal medium containing a suitable carbon source, nitrogen source, phosphorus source, inorganic compounds, amino acids, and / or vitamins, etc., under aerobic conditions while controlling temperature, pH, etc.

[0060] Specifically, a basic compound (e.g., sodium hydroxide, potassium hydroxide, or ammonia) or an acidic compound (e.g., phosphoric acid or sulfuric acid) may be used to adjust the pH to an appropriate level (e.g., pH 5 to 9, specifically, pH 6 to 8, most specifically, pH 6.8), but this is not intended to be limiting.

[0061] In addition, to maintain the culture in an aerobic state, oxygen or an oxygen-containing gas may be injected into the culture, or to maintain anaerobic and microaerobic states, no gas may be injected or nitrogen, hydrogen or carbon dioxide gas may be injected, but this is not limiting.

[0062] The culture temperature may be maintained at 20 to 45° C. or 25 to 40° C., and the culture may be performed for about 10 to 160 hours, but is not limited thereto. During the culture, the generation of bubbles may be suppressed using an antifoaming agent such as a fatty acid polyglycol ester, but is not limited thereto.

[0063] The carbon source contained in the medium used in the step of culturing the Schizochytrium microalgae may be any one or more selected from the group consisting of glucose, fructose, maltose, galactose, mannose, sucrose, arabinose, xylose and glycerol, but is not limited thereto as long as it is a carbon source used in culturing microalgae.

[0064] The nitrogen source contained in the medium used in the step of culturing the Schizochytrium microalgae may be i) any one or more organic nitrogen sources selected from the group consisting of yeast extract, beef extract, peptone, and tryptone, or ii) any one or more inorganic nitrogen sources selected from the group consisting of ammonium acetate, ammonium nitrate, ammonium chloride, ammonium sulfate, sodium nitrate, urea, and MSG (monosodium glutamate), but is not limited thereto as long as it is a nitrogen source used in culturing microalgae.

[0065] The medium used in the step of culturing the Schizochytrium microalgae may contain, as a phosphorus source, potassium dihydrogen phosphate, dipotassium hydrogen phosphate, a corresponding sodium-containing salt, etc., individually or in combination, but is not limited thereto.

[0066] The step of recovering biomass from the microalgae, the culture of the microalgae, the dried culture, or the crushed dried culture may involve collecting the desired biomass using any suitable method known in the art, such as centrifugation, filtration, anion exchange chromatography, crystallization, and HPLC, and may further include a purification step.

[0067] Another aspect of the present application provides a method for producing bio-oil derived from Schizochytrium sp. microalgae, the method including: culturing Schizochytrium sp. CD01-1821 microalgae; and recovering lipids from the microalgae, a culture of the microalgae, a dried product of the culture, or a crushed product of the dried product.

[0068] The Schizochytrium microalgae, the bio-oil, the culture of the microalgae, the dried product of the culture, the crushed product of the dried product, and the step of culturing the microalgae are as described above.

[0069] The step of recovering lipids from the microalgae, the culture of the microalgae, the dried product of the culture, or the crushed product of the dried product may involve collecting the lipids of interest using any suitable method known in the art, such as centrifugation, filtration, anion exchange chromatography, crystallization, and HPLC, and may further include a purification step.

[0070] For example, lipids and lipid derivatives such as fatty aldehydes, fatty alcohols and hydrocarbons (e.g., alkanes) can be extracted with hydrophobic solvents such as hexane. Lipids and lipid derivatives can also be extracted using methods such as liquefaction, oil liquefaction and supercritical CO2 extraction. In addition, known microalgae lipid recovery methods include, for example, i) collecting cells by centrifugation, washing with distilled water, and then drying by freeze-drying, and ii) grinding the resulting cell powder and then extracting lipids with n-hexane (Miao, X and Wu, Q, Biosource Technology (2006) 97:841-846).

[0071] Another aspect of the present application provides a use of Schizochytrium sp. CD01-1821 microalgae, a culture of the microalgae, a dried product of the culture, or a crushed product of the dried product for producing biomass or bio-oil.

[0072] The Schizochytrium microalgae, the biomass, the culture of the microalgae, the dried product of the culture, and the crushed product of the dried product are as described above.

[0073] Yet another example of the present application provides a use of Schizochytrium sp. CD01-1821 microalgae, a culture of said microalgae, a dried product of said culture, or crushed product of said dried product for producing a feed composition or a food composition.

[0074] The Schizochytrium microalgae, the biomass, the culture of the microalgae, the dried product of the culture, and the crushed product of the dried product are as described above. Effect of the Invention

[0075] The novel Thraustochytrid microalgae of the present invention has a high fat content in the biomass, and in particular, a high content of unsaturated fatty acids such as docosahexaenoic acid and eicosapentaenoic acid, so that it is very easy to extract the biomass itself or the biomass produced by culture and fermentation, and the fat components containing unsaturated fatty acids from the biomass. Therefore, the microalgae, the dried biomass and the bio-oil produced therefrom can be usefully used in feed compositions or food compositions. [Brief description of the drawings]

[0076] [Figure 1] FIG. 1 is a schematic diagram showing the process of isolating a Thraustochytrid microalgae strain. [Diagram 2] FIG. 2 shows the results of analyzing the total lipid content and the omega-3 fatty acid contents of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) of 29 isolated species of Thraustochytrid microalgae. [Diagram 3] FIG. 3 is a photograph of the wild-type Schizochytrium sp. strain CD01-1821 observed with an optical microscope. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0077] The present invention will be described in more detail with reference to the following examples, which are merely illustrative of one or more specific examples, and are not intended to limit the scope of the present invention.

[0078] Example 1. Isolation of Thraustochytrid microalgae To isolate Thraustochytrid microalgae, environmental samples in the form of seawater, leaves and sediments were collected from a total of 40 locations along the coasts of Seochon, Gunsan, Buan and Yeonggwang-gun, the west coast of Korea. Sampling was carried out in specific areas where organic sediments were observed to have developed, and the collected environmental samples were transported to a laboratory environment within 7 days to remove other contaminants such as bacteria, microorganisms, mold and protozoa, except for the Thraustochytrid microalgae to be isolated. Through continuous microscopic examination, Thraustochytrid microalgae cells were isolated from samples that showed the characteristic morphology of Thraustochytrid microalgae and formed zoospores that could be observed during the life cycle or had an ectoplasmic network that was generated during the developmental stage (Figure 1). The isolation and culture medium used in the isolation process was modified YEP medium (yeast extract 0.1 g / L, peptone 0.5 g / L, MgSO4·7H2O 2 g / L, sea salt 50 g / L, H3BO3 5.0 mg / L, MnCl2 3.0 mg / L, CuSO4 0.2 mg / L, NaMo4·2H2O 0.05 mg / L, CoSO4 0.05 mg / L, ZnSO4·7H2O 0.7 mg / L, agar 15 g / L). Through several isolation and subculture processes, pure isolated colonies with the source of contamination removed were obtained, and the isolated colonies were placed on solid medium containing an antibiotic cocktail solution (0-50mg / L streptomycin sulfate, 0-30mg / L ampicillin, 0-30mg / L penicillin G, 0-30mg / L kanamycin sulfate) and again underwent a process of controlling and removing the source of contamination to obtain pure isolateable colonies.

[0079] Example 2. Cultivation evaluation of isolated microalgae and selection of superior strains The colonies isolated in Example 1 were subjected to a culture evaluation, and superior strains were selected.

[0080] Specifically, the colonies isolated in Example 1 were cultured in a 250 mL flask at 10 to 35°C and 100 to 200 rpm for about 2 days using modified GGYEP medium (glucose 5 g / L, glycerol 5 g / L, yeast extract 0.1 g / L, peptone 0.5 g / L, MgSO4·7H2O 2 g / L, sea salt 50 g / L, H3BO3 5.0 mg / L, MnCl2 3.0 mg / L, CuSO4 0.2 mg / L, NaMo4·2H2O 0.05 mg / L, CoSO4 0.05 mg / L, ZnSO4·7H2O 0.7 mg / L). Based on the culture results, 29 species of microalgae that can grow at temperatures of 30°C or higher, have excellent growth rates, and can ensure a sufficient amount of bacteria were selected. The selected microalgae strains were cultured on a scale in a 500 ml flask for two days in modified GYEP medium containing 30 g / L glucose as a carbon source at 30°C and 150 rpm. After confirming that all the carbon source added in the culture environment had been consumed over the two days, the entire culture medium was collected and dried overnight in a dry oven at 60°C to obtain biomass.

[0081] The lipid and polyunsaturated fatty acid content of the cultured microalgae was analyzed using the following method, and fatty acid-containing oil derived from microalgae using dried microalgae was measured using the following method. 8.3M hydrochloric acid solution (HCl) was added to 5g of dried microalgae, and the cell wall of the microalgae was hydrolyzed at 80°C, and then 30mL of ethyl ether and 20mL of petroleum ether were added, mixed for 30 seconds, and centrifuged. This process was repeated three times or more. The separated solvent layer was collected and transferred to a round flask whose weight had been measured in advance, and the solvent was removed by nitrogen purging and cooled and weighed in a desiccator. After drying, the weight of the dried oil was measured by subtracting the weight of the empty flask from the weight of the flask, and the total oil content was calculated. The docosahexaenoic acid (DHA) content in the oil was measured by gas chromatography after pretreatment with methanolic 0.5N NaOH and 14% trifluoroborane methanol (BF3).

[0082] [Formula 1] Total oil content (%) = (*oil g / dry cell mass g) x 100 *Oil g: flask weight after acid hydrolysis and solvent removal - empty flask weight

[0083] "Biomass" in Table 1 below means the concentration of bacterial cells in the culture medium, and may be used interchangeably with DCW (dry cell weight) in Table 2 below.

[0084] [Table 1]

[0085] (In the above table, TFA means total fatty acids and may be used interchangeably with crude fat or total lipids.)

[0086] As a result, as shown in Table 1 and Figure 2, two strains, CD01-1821 and CD01-1822, showed very high intracellular DHA content of 50% or more.

[0087] Based on the fatty acid analysis results, two strains, CD01-1821 and CD01-1822, which have excellent intracellular DHA content, were cultured and evaluated in a 5L-scale incubator. Seed culture was performed in a 500mL flask using sterilized MJW02 medium (glucose 30g / L, MgSO4·7H2O 3.0g / L, Na2SO4 15g / L, NaCl 0.8g / L, yeast extract 1.0g / L, MSG·1H2O 1.0g / L, NaNO3 1.0g / L, KH2PO4 0.8g / L, K2HPO4 1.5g / L, CaCl2 0.5g / L, vitamin mixture solution 10ml / L) at 30℃ and 150 rpm for approximately 24 hours. The flasks containing the seed culture were dispensed and inoculated into a 5L incubator. A glucose carbon source of 28% was supplied to the total culture solution, and the culture was carried out for approximately 72 hours under the conditions of 30°C, 500 rpm, 1.5 vvm, and pH 5 to 8 in sterilized MJW02 medium and culture environment.

[0088] [Table 2]

[0089] As a result, as shown in Table 2, it was confirmed that the CD01-1821 strain has a higher total biomass production and crude fat production than the CD01-1822 strain under the same fermentation conditions, making it easier to scale up. Therefore, the CD01-1821 strain was selected and used to identify the strain sequence and develop additional strains. The morphology of the selected CD01-1821 strain was observed using an optical microscope and is shown in Figure 3.

[0090] Example 3. Confirmation of the culture characteristics of the CD01-1821 strain under complex carbon source conditions In heterotrophic microorganism-based fermentation, glucose is mainly used as a carbon source raw material. Glucose is a monosaccharide that is refined to over 90%, and is more expensive during industrial-scale fermentation than other carbon source raw materials. In order to use inexpensive carbon source raw materials and thereby ensure price competitiveness, it is important to discover microorganisms that can be used during fermentation without using refined glucose and that can be normally cultured with inexpensive carbon source components.

[0091] Therefore, the CD01-1821 strain and the CJM01 (registered patent 10-2100650) strain selected in Example 2 were subjected to fermentation culture evaluation using raw sugars mainly composed of glucose, fructose or sucrose to confirm the culture characteristics. The culture was performed in a 30L culture vessel, and the main carbon source components were glucose 450g / L, a mixture of glucose 225g / L and fructose 225g / L, and raw sugar decomposition products containing glucose 225g / L, fructose 220g / L and sulfate 1.51g / L, respectively, based on the modified MJW02 medium. The culture conditions were set to be the same, at 30°C, 500rpm, 1.5vvm, and pH 5-8, and the carbon source was supplied at 35% of the total culture liquid volume.

[0092] [Table 3]

[0093] As a result, as shown in Table 3, the CD01-1821 strain showed equal or higher levels of total biomass production and crude fat production when fermented under medium conditions of a fructose mixture or crude sugar hydrolysate, rather than a single glucose component. In contrast, the CJM01 strain showed a phenomenon in which sugar components other than glucose were added to the medium, resulting in consumption of dual carbon sources and a diauxic growth pattern of cells, resulting in a longer total culture time. Through these experimental results, it was confirmed that the CD01-1821 strain has the potential for scale-up fermentation under complex carbon source conditions.

[0094] Example 4. Identification of the novel Schizochytrium sp. strain CD01-1821 For molecular biological identification of the microalgae strain CD01-1821 isolated and selected in Examples 1 and 2, the 18S rRNA gene sequence was analyzed.

[0095] Specifically, gDNA was extracted and separated from a colony of the pure isolated microalgae CD01-1821, and then PCR amplification reaction was performed using the gene amplification primers 18s-Fwd and LABY-ARev for the 18s rRNA site listed in Table 4.

[0096] [Table 4]

[0097] The PCR reaction was carried out using a reaction solution containing taq polymerase, which was denatured at 95°C for 5 minutes, followed by 35 cycles of denaturation at 95°C for 30 seconds, annealing at 50°C for 30 seconds, and polymerization at 72°C for 2 minutes, followed by polymerization at 72°C for 5 minutes. The reaction solution amplified through the PCR process was electrophoresed on a 1% agarose gel to confirm that a DNA fragment of approximately 1000 bp in size had been amplified, and then subjected to base sequence sequencing analysis. As a result of the analysis, the sequence obtained showed 95.11% homology with the 18S rRNA gene sequence of Schizochytrium limacinum strain OUC109, which belongs to the Thraustochytrid family of microalgae, through an NCBI BLAST search, and 95.0% homology with the 18S rRNA gene sequence of Schizochytrium sp. strain LY-2012. Through this, it was confirmed that the isolated microalgae CD01-1821 is a new Schizochytrium strain, and it was named Schizochytrium sp. strain CD01-1821 and deposited at the Korea Comprehensive Biotechnology and Technology Center (KCTC) on August 23, 2021, and was assigned the accession number KCTC14660BP.

[0098] Example 5. Analysis of crude protein content of CD01-1821 strain culture samples The crude protein content of culture samples of Schizochytrium sp. CD01-1821 (and CD01-2147) was analyzed using the following method.

[0099] Specifically, the dried fermentation liquid (sample) equivalent to about 20-30 mg of dried bacteria was precisely measured and placed in a decomposition tube, followed by adding two grains of decomposition promoter. The decomposition promoter requires a ratio of sulfuric acid (H2SO4) and potassium sulfate (K2SO4) of 1.4-2.0:1.0 for efficient decomposition. Then, 12-15 mL of concentrated sulfuric acid (H2SO4) was added to the decomposition tube, and the tube was decomposed in a decomposition apparatus at 420°C for 45 to 60 minutes until the decomposition liquid turned a transparent light blue (when a copper catalyst was used) or a transparent yellow (when a selenium catalyst was used), and then cooled to room temperature. After cooling, 80 mL of distilled water was added to the decomposed test solution. 25 mL of the mixed indicator-mixed collection solution was placed in an Erlenmeyer flask, which was then placed in a distillation apparatus, and the Erlenmeyer flask stand was raised so that the distilled liquid would enter the collection solution during distillation. 50mL of sodium hydroxide solution (NaOH) (equivalent to 4 times the amount of sulfuric acid used in digestion) was placed in the digestion tube and distilled for 3 to 4 minutes in a distillation apparatus. It was confirmed that the collecting solution in the Erlenmeyer flask of the distillation apparatus turned green while collecting the ammonia (NH3) contained in the distillate. The distillate was titrated with hydrochloric acid solution (usually 0.1N or 0.2N) until the end point turned a light pink color, and the amount of acid used in the titration was recorded. In the case of an automatic apparatus, the distillation, titration, and calculation processes were all performed automatically. Using the above experimental results, the nitrogen % was calculated using the following calculation formula 2. Protein quantification was expressed by multiplying the nitrogen % calculated earlier by the average nitrogen coefficient of 6.25.

[0100] [Formula 2] Nitrogen (%) = {(HCl amount in mL - blank test in mL) x M x 14.01 / sample amount in mg} x 100 *14.01: Atomic weight of nitrogen *M: Molar concentration of HCl *Decomposition accelerator: Kjeltabs or equivalent *Boric acid solution: 100g (or 400g) of H3BO3, 100mL of 0.1% bromocresol green solution, and 100mL of 0.1% methyl red solution, adjusted to a volume of 10L to make a 1% (or 4%) boric acid solution.

[0101] For the analysis of amino acid content, about 1 g of fermentation liquid dry matter (specimen) sample was taken from the CD01-1821 strain culture liquid. After acid hydrolysis of intracellular proteins using 6N HCl solution, it was diluted with distilled water, filtered, and subjected to liquid chromatography.

[0102] [Table 5]

[0103] As a result, as shown in Table 5, it was confirmed that the crude protein content in the dried cells of CD01-1821 was 17%. In addition, the amino acid content in the dried cells was highest for glutamic acid, followed by tyrosine, alanine, phenylalanine, glycine, arginine, serine, valine, lysine, aspartic acid, methionine, isoleucine, and leucine, in that order. This confirmed that the amino acids in the dried cells of CD01-1821 were composed of glutamic acid, tyrosine, alanine, phenylalanine, glycine, arginine, serine, valine, lysine, aspartic acid, methionine, isoleucine, and leucine.

[0104] From the above description, a person having ordinary skill in the art to which the present application pertains should understand that the present application can be implemented in other specific forms without changing its technical ideas or essential features. In this regard, it should be understood that the above-described embodiments are illustrative in all respects and are not limiting. The scope of the present application should be interpreted as including all modifications or alterations derived from the meaning and scope of the claims below rather than the above detailed description, and the equivalent concepts thereof.

[0105] [Accession number] Name of depository institution: Korea Comprehensive Biological Resource Center (KCTC) Accession number: KCTC14660BP Date of acceptance: 20210823 JPEG2024542170000007.jpg245168

Claims

1. A novel Schizochytrium sp. CD01-1821 microalgae (Accession number: KCTC14660BP).

2. The Schizochytrium microalgae according to claim 1, wherein the Schizochytrium CD01-1821 microalgae has the ability to produce omega-3 unsaturated fatty acids.

3. The Schizochytrium microalgae according to claim 2, wherein the omega-3 unsaturated fatty acids are docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA).

4. The Schizochytrium microalgae according to claim 3, which produces 35 to 60% by weight of docosahexaenoic acid based on the total weight of fatty acids.

5. The Schizochytrium microalgae according to claim 3, which produces 0.1 to 2% by weight of eicosapentaenoic acid based on the total weight of fatty acids.

6. A biomass derived from Schizochytrium microalgae comprising the Schizochytrium microalgae according to claim 1, a culture of the microalgae, a dried product of the culture, or a crushed product of the dried product.

7. A composition comprising a biomass derived from the Schizochytrium microalgae of claim 6, a concentrate or dried product of said biomass, or an extract of said biomass.

8. The composition according to claim 6, wherein the composition is a feed composition or a food composition.

9. A method for producing biomass derived from Schizochytrium microalgae, comprising: culturing the Schizochytrium CD01-1821 microalgae according to claim 1; and recovering a biomass containing docosahexaenoic acid from the microalgae, a dried product thereof, or a crushed product thereof.

10. The method for producing biomass derived from Schizochytrium microalgae according to claim 9, wherein the culture is carried out under heterotrophic conditions.

11. The biomass production method according to claim 9 , wherein the culture is carried out in a medium containing a carbon source and a nitrogen source.

12. The method for producing biomass according to claim 11, wherein the carbon source is one or more selected from the group consisting of glucose, fructose, maltose, galactose, mannose, sucrose, arabinose, xylose and glycerol.

13. The method for producing biomass derived from Schizochytrium microalgae according to claim 11, wherein the nitrogen source is one or more organic nitrogen sources selected from the group consisting of i) yeast extract, beef extract, peptone and tryptone, or ii) one or more inorganic nitrogen sources selected from the group consisting of ammonium acetate, ammonium nitrate, ammonium chloride, ammonium sulfate, sodium nitrate, urea and MSG (Monosodium glutamate).

14. A method for producing bio-oil derived from Schizochytrium microalgae, comprising: culturing the Schizochytrium CD01-1821 microalgae according to claim 1; and recovering a biomass containing docosahexaenoic acid from the microalgae, a dried product thereof, or a crushed product thereof.

Citation Information

Patent Citations

  • Novel microorganism capable of producing docosahexaenoic acid and production of docosahexaenoic acid with the same

    JP1997000284A

  • Enhanced production of lipids containing polyenoic fatty acids by very high density cultures of eukaryotic microbes in fermenters

    JP2016202189A

  • NOVEL SCHIZOCHYTRIUM STRAIN AND METHOD FOR PRODUCING POLYUNSATURATED FATTY ACIDS USING THE SAME

    JP7621489B2

  • Mutant microalgae Schizochytrium sp. SHG104 strain having high productivity of carotenoid-type antioxidant pigment and bio-oil containing DHA and uses thereof

    KR101847551B1

  • The production method of docosahexanoic acid(DHA) with schizochytrium mangrovei mm103

    KR1020080111586A